ION BEAM APPLICATIONS (IBAB.BR) Fundamental Analysis & Valuation
EBR:IBAB • BE0003766806
Current stock price
14.2 EUR
+0.9 (+6.77%)
Last:
This IBAB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. IBAB.BR Profitability Analysis
1.1 Basic Checks
- In the past year IBAB was profitable.
- IBAB had a positive operating cash flow in the past year.
- IBAB had positive earnings in 4 of the past 5 years.
- In multiple years IBAB reported negative operating cash flow during the last 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 2.71%, IBAB is in line with its industry, outperforming 41.27% of the companies in the same industry.
- With an excellent Return On Equity value of 14.29%, IBAB belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 16.28%, IBAB belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROIC | 16.28% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 2.85%, IBAB is doing worse than 61.90% of the companies in the same industry.
- IBAB's Profit Margin has declined in the last couple of years.
- IBAB's Operating Margin of 6.48% is on the low side compared to the rest of the industry. IBAB is outperformed by 60.32% of its industry peers.
- IBAB's Operating Margin has declined in the last couple of years.
- Looking at the Gross Margin, with a value of 31.21%, IBAB is doing worse than 85.71% of the companies in the same industry.
- In the last couple of years the Gross Margin of IBAB has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% |
OM growth 3Y17.29%
OM growth 5Y-18.98%
PM growth 3Y6.89%
PM growth 5Y-27.51%
GM growth 3Y-2.84%
GM growth 5Y-5.9%
2. IBAB.BR Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBAB is creating value.
- IBAB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of 1.69, we must say that IBAB is in the distress zone and has some risk of bankruptcy.
- IBAB's Altman-Z score of 1.69 is on the low side compared to the rest of the industry. IBAB is outperformed by 66.67% of its industry peers.
- IBAB has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
- With a decent Debt to Equity ratio value of 0.23, IBAB is doing good in the industry, outperforming 68.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.69 |
ROIC/WACC2.09
WACC7.79%
2.3 Liquidity
- A Current Ratio of 0.94 indicates that IBAB may have some problems paying its short term obligations.
- IBAB has a worse Current ratio (0.94) than 84.13% of its industry peers.
- A Quick Ratio of 0.62 indicates that IBAB may have some problems paying its short term obligations.
- IBAB has a worse Quick ratio (0.62) than 80.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 |
3. IBAB.BR Growth Analysis
3.1 Past
- IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.86%, which is quite impressive.
- Measured over the past years, IBAB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -16.73% on average per year.
- Looking at the last year, IBAB shows a very strong growth in Revenue. The Revenue has grown by 21.86%.
- The Revenue has been growing by 14.73% on average over the past years. This is quite good.
EPS 1Y (TTM)41.86%
EPS 3Y27.82%
EPS 5Y-16.73%
EPS Q2Q%-21.38%
Revenue 1Y (TTM)21.86%
Revenue growth 3Y19.74%
Revenue growth 5Y14.73%
Sales Q2Q%8.09%
3.2 Future
- The Earnings Per Share is expected to grow by 35.60% on average over the next years. This is a very strong growth
- Based on estimates for the next years, IBAB will show a decrease in Revenue. The Revenue will decrease by -0.86% on average per year.
EPS Next Y78.85%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y3.53%
Revenue Next 3Y3.47%
Revenue Next 5Y-0.86%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. IBAB.BR Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 33.02, the valuation of IBAB can be described as expensive.
- The rest of the industry has a similar Price/Earnings ratio as IBAB.
- The average S&P500 Price/Earnings ratio is at 27.34. IBAB is valued slightly more expensive when compared to this.
- The Price/Forward Earnings ratio is 13.72, which indicates a correct valuation of IBAB.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of IBAB indicates a rather cheap valuation: IBAB is cheaper than 82.54% of the companies listed in the same industry.
- IBAB is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.18, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.02 | ||
| Fwd PE | 13.72 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IBAB is valued cheaply inside the industry as 84.13% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.01 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as IBAB's earnings are expected to grow with 35.60% in the coming years.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y38.16%
EPS Next 3Y35.6%
5. IBAB.BR Dividend Analysis
5.1 Amount
- IBAB has a Yearly Dividend Yield of 1.36%.
- Compared to an average industry Dividend Yield of 1.23, IBAB pays a bit more dividend than its industry peers.
- IBAB's Dividend Yield is slightly below the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.36% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- IBAB pays out 8.05% of its income as dividend. This is a sustainable payout ratio.
DP8.05%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
IBAB.BR Fundamentals: All Metrics, Ratios and Statistics
EBR:IBAB (4/14/2026, 7:00:00 PM)
14.2
+0.9 (+6.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-27 2026-03-27/amc
Earnings (Next)05-09 2026-05-09
Inst Owners27.34%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner ChangeN/A
Market Cap429.98M
Revenue(TTM)620.22M
Net Income(TTM)17.00M
Analysts80
Price Target16.07 (13.17%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.36% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.28%
PT rev (3m)9.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.22%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.37%
Revenue NY rev (3m)-0.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.02 | ||
| Fwd PE | 13.72 | ||
| P/S | 0.72 | ||
| P/FCF | N/A | ||
| P/OCF | 154.45 | ||
| P/B | 3.61 | ||
| P/tB | 4.56 | ||
| EV/EBITDA | 9.01 |
EPS(TTM)0.43
EY3.03%
EPS(NY)1.04
Fwd EY7.29%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.65%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.42
PEG (5Y)N/A
Graham Number6.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.71% | ||
| ROE | 14.29% | ||
| ROCE | 25.19% | ||
| ROIC | 16.28% | ||
| ROICexc | 17.24% | ||
| ROICexgc | 20.74% | ||
| OM | 6.48% | ||
| PM (TTM) | 2.85% | ||
| GM | 31.21% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y17.29%
OM growth 5Y-18.98%
PM growth 3Y6.89%
PM growth 5Y-27.51%
GM growth 3Y-2.84%
GM growth 5Y-5.9%
F-Score6
Asset Turnover0.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.54 | ||
| Cap/Depr | 65.94% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 5.44% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.94 | ||
| Quick Ratio | 0.62 | ||
| Altman-Z | 1.69 |
F-Score6
WACC7.79%
ROIC/WACC2.09
Cap/Depr(3y)87.67%
Cap/Depr(5y)76.45%
Cap/Sales(3y)2.06%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.86%
EPS 3Y27.82%
EPS 5Y-16.73%
EPS Q2Q%-21.38%
EPS Next Y78.85%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue 1Y (TTM)21.86%
Revenue growth 3Y19.74%
Revenue growth 5Y14.73%
Sales Q2Q%8.09%
Revenue Next Year3.13%
Revenue Next 2Y3.53%
Revenue Next 3Y3.47%
Revenue Next 5Y-0.86%
EBIT growth 1Y38.72%
EBIT growth 3Y40.44%
EBIT growth 5Y-7.05%
EBIT Next Year88.61%
EBIT Next 3Y37.43%
EBIT Next 5YN/A
FCF growth 1Y85.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.43%
OCF growth 3YN/A
OCF growth 5YN/A
ION BEAM APPLICATIONS / IBAB.BR Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?
ChartMill assigns a fundamental rating of 3 / 10 to IBAB.BR.
What is the valuation status of ION BEAM APPLICATIONS (IBAB.BR) stock?
ChartMill assigns a valuation rating of 5 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.
Can you provide the profitability details for ION BEAM APPLICATIONS?
ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 3 / 10.
What is the earnings growth outlook for ION BEAM APPLICATIONS?
The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 78.85% in the next year.
How sustainable is the dividend of ION BEAM APPLICATIONS (IBAB.BR) stock?
The dividend rating of ION BEAM APPLICATIONS (IBAB.BR) is 3 / 10 and the dividend payout ratio is 8.05%.